Shanghai Key Laboratory of New Drug Design;
School of Pharmacy;
East China University of Science and Technology;
Shanghai 200237;
China;
Research and Development Department;
Jiangzhong Pharmaceutical Co.;
Ltd.;
Nanchang 330096;
China;
JAK2; Selectivity; Inhibitors; Cancer; Structure-activity relationships;